The CABANA Research Trial

Published on May 9, 2012

Mayo Clinic’s Douglas L. Packer, M.D., the principal investigator of the Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) trial, presents an overview of CABANA and encourages eligible patients to enroll as well as medical professionals to refer their atrial fibrillation patients to this important clinical trial. CABANA will help establish the appropriate roles for which therapy (medical versus ablation) works best for treating atrial fibrillation, decreasing the associated symptoms and complications, and how these therapies impact the quality of life of patients. The CABANA study is being conducted in collaboration with the NHLBI, Mayo Clinic, Duke Clinical Research Institute, and the CABANA Research Centers. These centers all over the world are participating in the trial and the 3,000 participants will receive additional attention, access to immediate health care, extra opportunities to monitor their heart rhythm and report their symptoms compared to most patients being treated for atrial fibrillation outside of the CABANA trial. More information on the CABANA trial and how/where to enroll can be found at:



Douglas L. Packer M.D
CABANA Trial Principal Investigator
Mayo Clinic, Rochester MN


TARGET: 2200



Kerry L. Lee PhD

CABANA Trial Statistical Principal Investigator DCRI, Durham NC
Daniel B. Mark

Daniel B. Mark, MD, MPH

CABANA Trial Economics and Quality of Life Principal Investigator DCRI, Durham NC

Kristi Monahan, RN

CABANA Trial Director Mayo Clinic, Rochester MN

Upcoming Events

Date: Wednesday, May 09th, 2018

Time: 8:00PM EDT Social Hour
Time: 9:00PM EDT Doors lock, CABANA Results Presentation for Study Personnel

Location: Westin Boston Waterfront

Grand Ballroom C-D
425 Summer Street
Boston, MA  02210
PH:  617-532-4853


Heart Rhythm Society Scientific Sessions
09 – 12 MAY 2018
Boston, MA

CABANA HRS 2018 Presentation Slides